GET THE APP

Breast Cancer Mortality in Relation to Clinical Stage and Type of Surgical Procedure
..

Journal of Surgery

ISSN: [Jurnalul de chirurgie]
ISSN: 1584-9341

Open Access

Announcement - (2023) Volume 19, Issue 3

Breast Cancer Mortality in Relation to Clinical Stage and Type of Surgical Procedure

Milos Pocekovac1, Vladimir Djukic1, Predrag Savic1, Mirjana Stojanovic1, Miljan Milanovic1, Sladjana Markovic2 and Jovo Paskas1*
*Correspondence: Jovo Paskas, Clinical Hospital Center Dr. Dragisa Misovic-Dedinje, Belgrade, Heroja Milana Tepi?a 1, Beograd 11000, Serbia, Tel: +381641953986, Email:
1Clinical Hospital Center Dr. Dragisa Misovic-Dedinje, Belgrade, Heroja Milana Tepića 1, Beograd 11000, Serbia
2In Medis – Internal medicine office, Belgrade, Kneza Miloša 57, Beograd, Serbia

Received: 01-Apr-2023, Manuscript No. JOS-23-94875; Editor assigned: 03-Apr-2023, Pre QC No. P-94875; Reviewed: 17-Apr-2023, QC No. Q-94875; Revised: 22-Apr-2023, Manuscript No. R-94875; Published: 29-Apr-2023 , DOI: 10.37421/1584-9341.2023.19.89
Citation: Pocekovac, Milos, Vladimir Djukic, Predrag Savic and Mirjana Stojanovic, et al. “Breast Cancer Mortality in Relation to Clinical Stage and Type of Surgical Procedure.” J Surg 19 (2023): 89.
Copyright: © 2023 Pocekovac M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Introduction: Breast cancer represents a malignant lump in the breast that can cause a change in the shape of the breast, a change in the color of the skin of the breast, indentation of the breast and discharge from the nipple.

The aim: The aim of this study was monitoring of all the patients who were diagnosed with breast cancer and were treated in the regional center in Kruševac.

Material and methods: All patients operated on by one of the methods were monitored, and the date of the last control was taken as relevant data for the assessment of DFI and OS (Disease free interval - the period from setting up a diagnosis to the first relapse and Overall survival – the total survival in both groups. The percentage of mortality in both groups in relation to the clinical stage of the disease was analyzed.

Results: The largest number of patients underwent modified radical mastectomy, more than three times more than with breast-conserving surgery. Unfortunately, in 5.01% of patients only a biopsy was performed, which confirms the diagnosis of inoperable cancer, while the fate of 5 diagnosed cancers is unknown. There is no statistically significant difference in the percentage of mortality in both groups of patients operated on by modified radical mastectomy and patients operated on by breast-conserving surgery, up to stage IIIa, (t=0.39, p>0.05).

Conclusion: Analysis of the percentage of mortality did not show statistically significant differences in the percentage of mortality in both groups operated with modified radical mastectomy and breast-conserving surgery at the same clinical stage and for the same time period.

Keywords

Breast cancer • Surgical procedures

Introduction

Breast cancer is the leading cause of death from malignant diseases of women in the world, including our country [1]. Despite of significant discoveries in the recognition of prognostic and predictive factors, patients still die in a large percentage due to the metastatic spread of the disease. Early stage diagnosis allows a potential cure. If the cancer begins to spread to distant organs, the therapy has only palliative significance [2].

The share of breast cancer in mortality from malignant diseases is facilitated by adequate planning of treatment, determination of prognosis and assessment of treatment results [3]. Breast cancer is subject to the TNM classification, which is based on the determination of tumor size (T), the status of regional lymph glands determined by clinical examination (N), and the presence of distant metastases (M), based on standard diagnostic work-up (Table 1).

Table 1: Grouping by stages.

Stage T N M
Stage 0 Tis N0 M0
Stage I T1 N0 M0
Stage IIA T0 N1 M0
T1 N1 M0
T2 N0  
Stage II B T2 N1 M0
T3 N0 M0
Stage III A T0 N2 M0
T1 N2 M0
T2 N2 M0
T3 N1,  N2 M0
Stage III B T4 N0,  N1,  N2 M0
Stage III C any T N3 M0
Stage IV any T any N M1
Tis in situ; Tl-< 2cm; T1 mic< 0, 1 cm; Tla> 0, 1 do 0, 5 cm; Tlb>0, 5 do 1 cm; Tlc>l do 2 cm; T2>2 do 5 cm; T3>5cm; T4 chest wall / skin; T4a chest wall; T4b skin edema / ulceration, satellite nodule in the skin T4c оба 4a i ab; T4d inflammatory carcinoma N
N1 movable axillary pNl micrometastasis >0.2 mm
pN1a 1-3 axillary nodes
pN1b metastasis in internal mammary nodes detected by sentinel lymph node biopsy which is not clinically obvious
pN1c 1-3 axillary lymph nodes and nodes along the internal mammary with microscopic metastasis detected by sentinel lymph node biopsy that is not clinically apparent
N2a fixed axillary pN2a 4-9 axillary nodes
N2b internal mammary nodules pN2b internal mammary nodules, clinically evident, without axillary nodules
N3a infraclavicular pN3a 10 axillary lymph nodes or infraclavicular lymph node(s)
N3b internal and axillary mammary nodules pN3b internal mammary nodes, clinically apparent, with axillary node(s) or >3 axillary nodes with microscopic metastasis in internal mammary nodes detected by sentinel lymph node biopsy that is not clinically apparent

Breast cancer treatment involves the teamwork of surgeons, pathologists, radiologists and chemotherapists. Depending on the indications, surgical therapy today consists of modified radical mastectomy and breast-conserving surgery (Figure 1).

surgery-breast-cancer

Figure 1. Lymphatic pathways of breast cancer spread.

Material and Methods

The analysis includes 339 breast cancer patients diagnosed and treated at the regional center in Kruševac. All patients operated on by one of the methods were monitored, and the date of the last control was taken as relevant data for the assessment of DFI and OS (Disease free interval - the period from diagnosis to the first relapse and Overall survival - overall survival in both groups. The percentage of mortality in both was analyzed groups in relation to the clinical stage of the disease.

Work results

The largest number of patients was operated on with a modified radical mastectomy, more than three times more than with breast-conserving operation. Unfortunately, in 5.01% of patients only a biopsy was performed, which confirms the diagnosis of inoperable cancer, while the fate of 5 diagnosed cancers is unknown (Figure 2 and Table 2).

For stages from 0-IIIa t=0.39, p>0.05

surgery-distribution

Figure 2. Distribution of patients according to the type of operation.

Table 2: Mortality according to type of operation and clinical stage.

Type of operation Clinical stage In total
0 I IIa IIb IIIa IIIb IV
1 Modified radical mastectomy 1 34 90 125 26 8 4 287
0 3 7 21 10 5 2 48
(0,00%) (8,82%) (7,77%) (16,18%) (38,46%) (62,50%) (66,66%)  
2 Breast-conserving operation 0 9 6 9 8 29 26 87
0 0 1 2 1 7 19 30
(0,00%) (0,00%) (16,66%) (22,22%) (12,50%) (23,33%) (63,33%)  
3 Only a biopsy 1 2 2 1 3 7 4 20
0 0 0 0 2 3 2 7
(0,00%) (0,00%) (0,00%) (0,00%) (66,66%) (42,85%) (50,00%)  
4 Unknown 0 0 0 0 0 3 2 5
5 In total 2 45 98 135 37 47 35 399
0 3 8 23 13 15 23 85

There is no statistically significant difference in the percentage of mortality in both groups up to stage IIIa, (t=0.39, p>0.05). After that, locally advanced breast cancers, especially if they are inflamed and accompanied by bleeding, indicate a mastectomy out of comfort in order to improve the quality of life (Figure 3).

surgery-mortality

Figure 3. Mortality in breast cancer according to clinical stage depending on the type of operation.

Discussion

Due to its epidemiological characteristics, breast cancer is the most significant malignant disease of women. Every year in Serbia, about 4,000 women fall ill, and 1,300 die. The World Health Organization has estimated that in this century every 8th woman on the planet will fall ill with this disease. The number of new patients is constantly increasing, worldwide by 1-2% per year, while in our country the percentage is much higher.

Early diagnosis of breast cancer, the use of neoadjuvant chemotherapy and post operational radiotherapy have enabled the use of breast-conserving surgery in recent decades. Breast-conserving surgery involves removal of the primary tumor while preserving the volume and symmetrical appearance of the breast and, most often, functional dissection of the axillary pit with postoperative radiotherapy of the rest of the breast and possibly regional lymph glands [4,5].

The goal of breast-conserving surgery is to make the treatment result equal to that one achieved by mutilation surgery, while at the same time providing the patient with a better quality of life because the breast is preserved. The aesthetic result therefore plays an important role in breast conservation surgery [6,7]. The surgical technique of breast-conserving operations was developed from the surgical technique of modified radical mastectomy at a time when radical surgical treatment was given more importance than it actually has [8]. In our study, 399 patients with breast cancer were included, where more than three times as many underwent modified radical mastectomy than breast-conserving surgery.

Conclusion

Analysis of the percentage of mortality did not show statistically significant differences in the percentage of mortality in both groups operated at the same clinical stage and for the same time period.

Acknowledgement

None.

Conflict of Interest

None.

References

  1. Bray, F, R. Sankila, J. Ferlay and D. M. Parkin. "Estimates of cancer incidence and mortality in Europe in 1995."Eur J Cancer 38 (2002): 99-166.
  2. Google Scholar, Crossref, Indexed at

  3. Bonetti, M, R. D. Gelber, A. Goldhirsch and M. Castiglione-Gertsch, et al. "Features that predict responsiveness to chemotherapy and endocrine therapies."Breast 10 (2001): 147-157.
  4. Google Scholar, Crossref, Indexed at

  5. Porkin, D. M. "The global burden of cancer." Semin Biol 8 (1998): 219-235.
  6. Sarrazin, Danièle, Monique Lê, Jacques Rouëssé and Geneviève Contesso, et al. "Conservative treatment vs. mastectomy in breast cancer tumors with macroscopic diameter of 20 millimeters or less the experience of the institut gustave‐roussy."Cancer53 (1984): 1209-1213.
  7. Google Scholar, Crossref, Indexed at

  8. Fisher, Bernard, Madeline Bauer, Richard Margolese and Roger Poisson, et al. "Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer."N Engl J Med 312 (1985): 665-673.
  9. Google Scholar, Crossref, Indexed at

  10. Jamison, Kay R, David K. Wellisch and Robert O. Pasnau. "Psychosocial aspects of mastectomy: I. The woman's perspective." Am J Psy 135 (1978): 135:432
  11. Google Scholar, Crossref, Indexed at

  12. https://www.booklooker.de/app/detail.php?id=A02C7fAA01ZZB&pid=76312&t=8waeme3mfme9f397
  13. Ivanović N. "Therapeutic and aesthetic effects of functional dissection of the axilla in breast cancer surgery." Doctoral Dissertation (2006).
Google Scholar citation report
Citations: 288

Journal of Surgery received 288 citations as per Google Scholar report

Journal of Surgery peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward